R.G. Niederhoffer Capital Management’s AbbVie ABBV Stock Holding History

R.G. Niederhoffer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,000	Closed	-$568K	–	29
2018 Q1	$568K	Buy	+6,000	New	+$659K	2.75%	14
2016 Q3	–	Sell	-34,800	Closed	-$2.15M	–	28
2016 Q2	$2.15M	Buy	+34,800	New	+$2.12M	13.66%	1
2015 Q4	–	Sell	-9,100	Closed	-$495K	–	2
2015 Q3	$495K	Buy	+9,100	New	+$592K	2.44%	14
2014 Q4	–	Sell	-5,200	Closed	-$301K	–	1
2014 Q3	$301K	Buy	+5,200	New	+$289K	2.35%	16

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

R.G. Niederhoffer Capital Management's ABBV Position: Q2 2018 in Review

R.G. Niederhoffer Capital Management sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 6,000 shares — an estimated $568K sold.

R.G. Niederhoffer Capital Management first reported a position in ABBV in Q3 2014 and held it in 4 quarters. The position peaked at $2.15M in Q2 2016. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

R.G. Niederhoffer Capital Management reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
R.G. Niederhoffer Capital Management sold 6,000 AbbVie shares in Q2 2018, an estimated $568K.
R.G. Niederhoffer Capital Management first reported a position in AbbVie in Q3 2014 and held it in 4 quarters.
R.G. Niederhoffer Capital Management's AbbVie position peaked at $2.15M in Q2 2016.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q2 2018, filed 7 Aug 2018.